GHK-Cu Research Notes
Selected PubMed sources, evidence limits, and current BioPep USA catalog and documentation status for GHK-Cu. Research use only.
Research-use-only scope: This article organizes published sources and BioPep USA records. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.
GHK-Cu literature spans culture systems, animal wound models, and biomaterial studies. Each model answers a different question.
Questions covered by the selected literature
- How GHK-related peptides were used in culture systems
- What an animal wound model measured
- How a copper-peptide biomaterial study differs from a standalone compound study
Evidence limits
The cited studies use culture, animal, or scaffold models. Their observations do not establish a human-use outcome for the BioPep USA product.
A paper should be read according to its own model, methods, controls, and endpoints. Cell, animal, analytical, review, and human records are not interchangeable.
Selected PubMed sources
- The use of glycylhistidyllysine in culture systems.. In Vitro. 1981 Jun. PMID: 7021400.
- In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.. J Clin Invest. 1993 Nov. PMID: 8227353.
- Biomimetic Hydrogel Scaffolds with Copper Peptide-Functionalized RADA16 Nanofiber Improve Wound Healing in Diabetes.. Macromol Biosci. 2022 Aug. PMID: 35598070.
BioPep USA record
BioPep USA currently lists GHK-Cu. Use the product page for current options and the documentation page for lot records.
Last reviewed: July 20, 2026.
